Page 2 - Shivam Tyagi

Lupin Q2 Preview: Profits may rise 42% YoY led by steady India, US sales

Brokerages expect Lupin to report a strong quarter on a year-on-year basis, while a quieter one sequentially

Dr Reddy's Labs Q2 Preview: Profits may decline 7%, revenues to rise 12%

Analysts expect Dr Reddy's Labs to report a single digit fall in profits with a double digit revenue growth

Stocks to Watch, Nov 4: Sun Pharma, Dr Reddy's, Zen Tech, Afcons Infra

Stocks to watch, November 4, 2024: Dr Reddy's Lab has announced a recall of over 331,000 bottles of Cinacalcet tablets sold in the US

Samvat 2081: Diwali picks from Kotak Sec, HDFC Sec, Nirmal Bang, JM Fin

Here's a list of top stock picks by select brokerages for Samvat 2081

Why Sensex fell 655 pts, Nifty below 24,200 ahead of Diwali Muhurat Trading

Indian bourses retreated heavily on Thursday, a day ahead of Diwali Muhurat Trading on November 1, with the BSE Sensex dropping 655 points or 0.81 per cent at 79,287.93 level

Cipla faces challenges of slow growth, drug launch; analysts slash target

Growth challenges galore; brokerages slash target price after subdued Q2 show

Analysts offer mixed views on Sun Pharma's near term growth; revise target

Shares of Sun Pharmaceuticals, the biggest pharmaceutical company of India fell 1.71 per cent at Rs 1870 per share on the BSE after brokerages offered mixed reviews post Q2

Key reasons why Sensex rose 1,100 pts, Nifty climbed 24,490 intraday today

After a challenging week for investors in Indian bourses, the markets finally turned positive on Monday, surging up to 1,137 points or 1.43 per cent and reclaiming the 80,000 mark at 80,539 levels

Cipla Q2 Preview: Analysts expect lukewarm growth in sales, profit

Analysts expect Cipla to register a low single digit rise in the topline and bottomline, with margins being impacted by modest sales in the US and domestic formulations

Crude oil to remain volatile in Samvat 2081 amid OPEC+ production cuts

Brent crude oil prices saw a considerable decline from the beginning of Samvat 2080 (November 12) until October 28, dropping by 12.33 per cent from $82.52 to $72.34 per barre

IndusInd Bank share drops 20% on poor Q2 show; analysts slash target price

IndusInd Bank share price news: IndusInd Bank saw an all-round miss in Q2 earnings and the weakest earnings growth in the sector, by any bank, so far

Sun Pharma Q2 Preview: Profit may rise by 19%, R&D spends to impact margins

Analysts expect Sun Pharma to register double digit growth in the topline and bottomline driven by specialty sales

Market Crash: Why Sensex plunged over 900 pts, Nifty fell below 24,500

In a volatile session on Tuesday, the BSE Sensex crashed up to 1002 points or 1.23 per cent to 80,433 levels, while NSE's Nifty50 fell 336 points or 1.35 per cent at 24,445.80 levels

Tata Consumer stock plunges 10% on meek profit, margin growth in Q2

The stock price slumped after the fast-moving consumer goods (FMCG) major reported a sluggish margin and profit growth in the second quarter of the current financial year (Q2FY25)

Don't mistake recent pullback in equities for a bear market: Vinit Sambre

As India Inc prepares to unveil its financial performance for the September 2024 (Q2-FY25) quarter, market movement going ahead will likely depend primarily on earnings growth, said Vinit Sambre

Brokerages bullish on HCL Tech post Q2FY25 outperformance, raise EPS target

Shares of HCL Tech hit their lifetime high at Rs 1,882, rising by 1.40 per cent on the BSE in Tuesday's intraday deals after the company delivered solid performance in its quarter two results

Infosys Q2 Preview: Co to lead Tier-I IT pack; profits may grow over 9% YoY

Analysts expect Infosys to log strong performance among its Tier-I IT peers, driven by large deal ramp-ups, integration of its subsidiary 'intech', and recovery in the banking and financial services

Federal Bank shares jump 5% after MOFSL reiterates 'Buy' with 23% upside

Federal Bank shares surged to Rs 196.05 a piece in intraday day deals, rising up to 4.64 per cent on Monday

HCL Tech Q2 Preview: Brokerages expect flat revenue, decline in TCV

The Indian IT major is expected to register a single digit rise in its topline and bottomline compared to the September quarter of FY24

TCS shares slip as brokerages offer mixed outlook, reduce earning estimates

Analysts believe that the earnings were satisfactory and were in line with their estimates, with an optimistic management waiting for a turnaround in the near future